Elevance cuts 2025 guidance as profit falls from higher ACA, Medicaid costs
The insurer attempted to reassure investors that it can operate through looming policy changes that appear set to worsen existing challenges. It was unsuccessful: Elevance’s stock fell 11% following the second quarter results.
Healthcare Dive
Adam Fard Blog
TechHive
The New York Times
Bright Classroom Ideas
The Property Investment Blog
MedCity News